Patent · US Active

Indazolyl triazol derivatives

US9073892B2 · kind B2 · utility

6Cited by
0References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 16, 2011
Grant dateJul 7, 2015
Priority date
Expiry dateDec 16, 2031

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of Formula (I)are used for the treatment of inflammation and autoimmune disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.